MEDICINE DETAILS
Stelara
Active ingredient: Ustekinumab
Neutral reference profile for an independent medicine-access consultancy enquiry about Stelara (Ustekinumab). No medicine is offered for sale.
NEXT STEP
Choose the strength and pack
✓ If you are unsure, choose “I do not know”.
These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.
ABOUT THIS MEDICINE
What is Stelara used for?
Stelara (ustekinumab) is an interleukin (IL)-12 and IL-23 antagonist (immunosuppressant) indicated for the treatment of:
- Moderate or severe plaque psoriasis in adults and children aged 6 years and older, whose condition has not improved with, or who cannot use, other systemic psoriasis treatments or phototherapy (UV light therapy)
- Active psoriatic arthritis in adults, with or without methotrexate
- Moderately to severely active Crohn's disease in adults, after other medicines have been tried without success
- Moderately to severely active ulcerative colitis in adults, after other medicines have been tried without success
It is available as a single-dose prefilled syringe containing 45 mg or 90 mg ustekinumab, or single-dose vials containing 45 mg ustekinumab for subcutaneous injection. It is also available in single-dose vials containing 130 mg ustekinumab for intravenous use.
This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.
RECORDED PRODUCT PROFILE
Stelara identity, dosage form and pack information.
The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.
Recorded strength and pack options
Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.
-
45 mg · 1 vial Catalogue organisation: JANSSEN-CILAG GmbH
-
45 mg solution for injection · 1 pen Catalogue organisation: Abacus Medicine A/S
-
45 mg solution for injection · 1 pre-filled syringe Catalogue organisation: CC Pharma GmbH
-
90 mg solution for injection · 1 pen Catalogue organisation: Abacus Medicine A/S
-
90 mg solution for injection · 1 pre-filled syringe Catalogue organisation: HAEMATO PHARM GmbH
-
130 mg concentrate for solution for infusion · 1 vial Catalogue organisation: Abacus Medicine A/S
OFFICIAL SOURCES
Check the Stelara record at an official source.
Search for “Stelara” or “Ustekinumab”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.
OFFICIAL EXTERNAL SOURCE
European Medicines Agency (EMA)
Search medicines evaluated by EMA by brand name or active substance. EMA also links to national registers for nationally authorised products.
↗ OFFICIAL EXTERNAL SOURCE Drugs@FDASearch FDA-approved human drug records by brand name or active ingredient, including current labelling where available.
↗SERVICE BOUNDARY
Information checking and independent enquiry support for Stelara.
OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.
Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.
CLEAR ANSWERS
Frequently asked questions about Stelara
01What is Stelara?＋
This directory record associates the brand name Stelara with the active ingredient Ustekinumab. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.
02Which Stelara strengths and packs are recorded?＋
The catalogue currently shows: 45 mg · 1 vial; 45 mg solution for injection · 1 pen; 45 mg solution for injection · 1 pre-filled syringe; 90 mg solution for injection · 1 pen. Check the complete strength, dosage form and pack description against the prescription and medicine box.
03Who manufactures Stelara?＋
Catalogue records currently name: JANSSEN-CILAG GmbH, Abacus Medicine A/S, CC Pharma GmbH. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.
04Do the listed options confirm stock or access?＋
No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.
05What affects a possible estimated medicine cost for Stelara?＋
A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Stelara, payment request, stock guarantee or binding offer.
06Can I buy Stelara from this website?＋
No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.